All Type of News
7 of 10 multinational pharmas reduce entertainment expenses due to Kim Young Ran Law
The Kim Young Ran Law enforced last year was analyzed to reduce entertainment expenses on multinational pharmaceutical companies.
According to the Yakup Shinmoon’s(www.yakup.com) analysis result of 2016 audit reports...
Pharma industry agrees need of preferential treatments on biologics, but HIRA says “Well…”
Which health insurance standards should biologics, which are evaluated as innovative treatment, meet?
The pharmaceutical industry believes that it is necessary to give preference to Korean new drugs and biologics for...
KPA finally recovered the ‘lost 26 years’ back
The Korean Pharmaceutical Association(KPA) succeeded in searching for the root to recover 26 years lost.
The KPA passed an agenda to change the foundation day from 8 November 1954, a day the inaugural meeting of the ...
Company returning innovative pharma certi. Respects MOHW’s decision, but a tad sorry
In regards to returning the innovative pharmaceutical company certificate to the Ministry of Health and Welfare(MOHW), the company A expressed a stance that the company respect the MOHW’s decision and is sorry about t...
‘Rebate-involved’ 2 pharmas lost position as innovative pharmaceutical company
The pharmaceutical companies which got involved with rebate was finally removed from the list of innovative pharmaceutical companies.
The Ministry of Health and Welfare removed the 2 companies that lost the position ...
Via Davinci and Hanlim MS recorded ‘highest’ KRW 36.4 billion dividends and 876% dividend payout ratio each
Pharmaceutical distribution companies paid the total KRW 93.3 billion dividends based on their performance of the last year. Among them, Via Davinci and Hanlim MS became the top in the amount of dividends and the divi...
Multinational pharmas’ trend to reduce advertising expenses by 7%
It was observed multinational pharmaceutical companies are reducing expenses for advertising.
It seems they have cut advertising expenses because there is no reason to increase them as most of their products are ETC ...
Pharma distributors narrowly increased in operating profit and net profit
Last year, pharmaceutical distribution companies were narrowly increased in operating profit and net profit.
According to the analysis result of 146 pharmaceutical distribution companies’ 2016 audit reports turned in...
MOTIE’s active support on ‘Personalized drug development and promotion on biopharmaceutical startups’
In order to become a pharmaceutical power in the world, the government will be active in promoting startups in the new personalized drug development and biopharmaceutical fields.
The Ministry of Trade, Industry and E...
MSD Korea’s antibody, Zerbaxa’s approval in Korea‘Zerbaxa(generic name: ceftolozane+tazobactam),’ a MSD Korea’s(CEO Avi BenShoshan) new antibody, acquired sales approval in Korea. On the 7th, the Ministry of Food and Drug Safe...
|
